Literature DB >> 15602718

Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine.

Fabrizio Maggi1, Elena Tempestini, Letizia Lanini, Elisabetta Andreoli, Claudia Fornai, Simone Giannecchini, Marialinda Vatteroni, Mauro Pistello, Santino Marchi, Pietro Ciccorossi, Steven Specter, Mauro Bendinelli.   

Abstract

Torque Teno virus (TTV) has been demonstrated to be present persistently in the blood of healthy individuals without evidence that it causes any disease process. The levels of TTV vary in patients co-infected with other viruses and there has been considerable speculation as to whether TTV contributes to pathogenesis by other viruses or if the varying levels might be related to immune activation in the host. In the present study, the load of TTV was examined in plasma and peripheral blood mononuclear cells (PBMCs) following immunization of subjects with either influenza (a recall antigen) or hepatitis B virus (HBV) (a new antigenic exposure). The results overall did not indicate a significant change in TTV titers over a 90 day observation period; however, when TTV genogroup was taken into consideration there was an increase in viral load in plasma at some time points for subjects persistently infected with genogroup 3. While this was observed in both influenza and HBV immunized subjects, the effect was more profound in HBV vaccination. Thus, it appears that exposure to a new antigen rather than a recall antigen may stimulate TTV replication more effectively. The data further suggest that investigating the interactions between TTV and its host might require to examine specifically each TTV genogroup separately in order to determine if certain TTV types have any role in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15602718     DOI: 10.1002/jmv.20278

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Rapid increase in total torquetenovirus (TTV) plasma viremia load reveals an apparently transient superinfection by a TTV of a novel group 2 genotype.

Authors:  Fabrizio Maggi; Elisabetta Andreoli; Letizia Lanini; Silvia Meschi; Jara Rocchi; Claudia Fornai; Maria Linda Vatteroni; Mauro Pistello; Mauro Bendinelli
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults.

Authors:  Mats Haloschan; Rainer Bettesch; Irene Görzer; Lukas Weseslindtner; Michael Kundi; Elisabeth Puchhammer-Stöckl
Journal:  Age (Dordr)       Date:  2014-10-05

3.  Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients.

Authors:  A Fuchs; N Lübke; L Schmidt; B-E O Jensen; A Walker; V Keitel-Anselmino; V di Cristanziano; M Böhm; E Knops; E Heger; R Kaiser; A de Luca; M Oette; D Häussinger; J Timm
Journal:  Infection       Date:  2021-02-03       Impact factor: 3.553

4.  Pre-transplant plasma Torque Teno virus load and increase dynamics after lung transplantation.

Authors:  Irene Görzer; Peter Jaksch; Michael Kundi; Tamara Seitz; Walter Klepetko; Elisabeth Puchhammer-Stöckl
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

5.  Blood hormones and torque teno virus in peripheral blood mononuclear cells.

Authors:  Peik M A Brundin; Britt-Marie Landgren; Peter Fjällström; Anders F Johansson; Ivan Nalvarte
Journal:  Heliyon       Date:  2020-11-21

6.  Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression.

Authors:  Savannah Mwesigwa; Lesedi Williams; Gaone Retshabile; Eric Katagirya; Gerald Mboowa; Busisiwe Mlotshwa; Samuel Kyobe; David P Kateete; Eddie Mujjwiga Wampande; Misaki Wayengera; Sununguko Wata Mpoloka; Angella N Mirembe; Ishmael Kasvosve; Koketso Morapedi; Grace P Kisitu; Adeodata R Kekitiinwa; Gabriel Anabwani; Moses L Joloba; Enock Matovu; Julius Mulindwa; Harry Noyes; Gerrit Botha; Chester W Brown; Graeme Mardon; Mogomotsi Matshaba; Neil A Hanchard
Journal:  NPJ Genom Med       Date:  2021-03-19       Impact factor: 8.617

7.  Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients.

Authors:  Fabrizio Maggi; Daniele Focosi; Maura Statzu; Gabriele Bianco; Cristina Costa; Lisa Macera; Pietro Giorgio Spezia; Chiara Medici; Eliseo Albert; David Navarro; Carolina Scagnolari; Mauro Pistello; Rossana Cavallo; Guido Antonelli
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.